
| Serial Number | 88166343 |
| Word Mark | HELIXMITH |
| Filing Date | Tuesday, October 23, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 12, 2019 |
| Registration Number | 5906698 |
| Registration Date | Tuesday, November 12, 2019 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 28, 2019 |
| Certificate of Correction for Registration | In the statement, Column 1, line 1-3,"are deleted", and HELIXMITH CO., LTD (Korea, republic of Corporation) 1 Gwanak-ro 5th Fl. Bldg. 203, Seoul, Korea, South 08826 should be inserted |
| Goods and Services | reagents for use in veterinary genetic testing for medical use; chemical preparations for pharmaceutical purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; chemical preparations for use in DNA analysis for medical use; drugs for medical purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; reagents for use in medical genetic testing for medical use; pharmaceutical drugs, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; medicines for human purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; pharmaceutical preparations for diagnosis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; ethical medicinal preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; therapeutic drugs and agents, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; crude medicines, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations for medical use in medical and clinical gene therapy and cell therapy; pharmaceutical preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations for medical use, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer |
| Pseudo Mark | HELIX MITH |
| Goods and Services | Retail store services featuring reagents for use in veterinary genetic testing; retail store services featuring chemical preparations for pharmaceutical purposes; retail store services featuring chemical preparations for use in DNA analysis for medical use; retail store services featuring drugs for medical purposes; retail store services featuring reagents for use in medical genetic testing; retail store services featuring pharmaceutical preparations for diagnosis; retail store services featuring pharmaceutical preparations for the treatment of immune system related diseases and disorders; retail store services featuring ethical medicinal preparations; retail store services featuring therapeutic drugs and agents, retail store services featuring biological preparations for medical use |
| Goods and Services | Research and development of vaccines and medicines; providing information relating to scientific analysis of the genetic information via online networks; scientific research in the fields of biomedicine; biological information analysis, namely, genetic testing for medical research purposes; biological information analysis, namely, genetic testing for scientific research purposes; research and testing services in the fields of bacteriology and virology; drug discovery services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy relating to the pharmaceutical research and development; pharmaceutical research and development; pharmaceutical research services; laboratory research in the field of gene expression; gene analysis for research; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of medicine/health and pharmacology; analysis of human serum for medical research; analysis of human tissues for medical research; blood analysis services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 5, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 5, 2018 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 5, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Helixmitth Co., Ltd |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Seoul 08826 KR |
| Party Name | ViroMed Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Seoul 08826 KR |
| Party Name | ViroMed Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seoul 08826 KR |
| Event Date | Event Description |
| Friday, October 26, 2018 | NEW APPLICATION ENTERED |
| Monday, November 5, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, January 3, 2019 | ASSIGNED TO EXAMINER |
| Saturday, January 5, 2019 | NON-FINAL ACTION WRITTEN |
| Saturday, January 5, 2019 | NON-FINAL ACTION E-MAILED |
| Saturday, January 5, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, March 5, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 8, 2019 | ASSIGNED TO LIE |
| Wednesday, March 13, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, March 13, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, March 22, 2019 | NON-FINAL ACTION WRITTEN |
| Friday, March 22, 2019 | NON-FINAL ACTION E-MAILED |
| Friday, March 22, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, March 29, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 29, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, March 30, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 3, 2019 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, April 3, 2019 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, April 3, 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, April 3, 2019 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, April 3, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, April 12, 2019 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Monday, April 22, 2019 | ELECTRONIC RECORD REVIEW COMPLETE |
| Wednesday, May 8, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 28, 2019 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 28, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 11, 2019 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Wednesday, June 19, 2019 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Sunday, October 6, 2019 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Tuesday, November 12, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, January 21, 2020 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Tuesday, December 3, 2019 | TEAS SECTION 7 REQUEST RECEIVED |
| Tuesday, January 21, 2020 | CORRECTION UNDER SECTION 7 - PROCESSED |
| Tuesday, February 18, 2020 | POST REGISTRATION ACTION CORRECTION |
| Tuesday, February 18, 2020 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Tuesday, February 18, 2020 | OTQR WITHDRAWAL FROM PUBLICATION |
| Wednesday, February 19, 2020 | POST REGISTRATION ACTION MAILED - SEC. 7 |
| Monday, August 10, 2020 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| Tuesday, August 25, 2020 | CORRECTION UNDER SECTION 7 - PROCESSED |
| Tuesday, November 12, 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |